Potential Markets

Through it MagPhase platform Spinomix addresses a large potential market that includes applications medical diagnostics & screening, life-science research and food & animal testing.

Medical diagnostics & screening

As diagnostic assays become increasingly complex, the need arises for affordable, automated and compact systems that can integrate multitude of functionalities yet are easy to operate. This trend is further driven by the move towards POC assays, a prerequisite for personalized front line medicine using various markers as targets for early disease detection or screening or for the development and testing of new drugs. Spinomix is able to provide cost efficient easy to operate and robust diagnostic systems that can be used for ultra-sensitive quantitative measurements.

Life-science research

The worldwide research market for biomolecules (such as nucleic acids and proteins) analysis products is comprised of an estimated 45'000 academic and industrial research laboratories with more than 39'000 researches from leading academic institutions, diagnostics companies and laboratories, biotechnology companies and pharmaceutical companies. Approximately $26 billion of that was used for biological studies and pharmacological testing - research functions that have a need for novel technologies allowing fast and sensitive biomolecules analysis.

On segment market on which Spinomix will particularly is the "sample preparation" market. Obviously, the successes of any bio-molecules analysis rely on the extraction or purification capabilities. The extraction and purification steps (= sample preparation steps) of proteins and nucleic acids (DNA/RNA) are complex steps that remains the most work-intensive part of processing and accounts for the majority of the time spent on assays. To accommodate the need, Spinomix SA can leverage the advantages of its magnetic particles based technologies to propose low cost, automated, and flexible system for sample preparation.

Food & Animal testing

The rising public demand for better and more comprehensive food-safety testing in general, promise to create extensive need for new food-safety testing. Moreover, while biotechnology companies hope to seduce U.S. consumers with engineered food products like low-fat corn, resistance to genetically modified content of any kind remains strong in the EU and other places, driving the need for more food quality control. At the same time, testing can be expected to continue to play a vital role in the food export business. To accommodate the needs, any technology must meet special requirements imposed by the complexity and the variety of matrix to be tested. Sample preparation is a huge issue as well. In fact, because pathogens like Microsporidia in water may be low concentrated, finding them with current technology can be like finding the proverbial needle in the haystack. In this context, Spinomix technology is the basis of developing new solution that allows efficient and improved sample concentration methods. Moreover, MagPhase platform is a solution for providing systems that assure portability, viability and versatility, key requirements of any new instruments for this market.